Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liposomes | 6 | 2018 | 24 | 1.160 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2022 | 197 | 1.030 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 62 | 0.840 |
Why?
|
| Integrin alpha4beta1 | 1 | 2018 | 2 | 0.550 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 7 | 0.540 |
Why?
|
| Drug Carriers | 2 | 2007 | 7 | 0.490 |
Why?
|
| Insulin | 2 | 2007 | 29 | 0.480 |
Why?
|
| Plaque, Amyloid | 1 | 2016 | 7 | 0.470 |
Why?
|
| Nanoparticles | 1 | 2016 | 69 | 0.430 |
Why?
|
| Animals | 7 | 2023 | 1711 | 0.430 |
Why?
|
| Mice | 4 | 2023 | 685 | 0.390 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 225 | 0.280 |
Why?
|
| Glucose | 1 | 2007 | 13 | 0.250 |
Why?
|
| Ligands | 3 | 2021 | 55 | 0.230 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2 | 0.230 |
Why?
|
| Folic Acid | 1 | 2005 | 4 | 0.230 |
Why?
|
| Carrier Proteins | 1 | 2005 | 23 | 0.220 |
Why?
|
| Drug Delivery Systems | 1 | 2004 | 26 | 0.220 |
Why?
|
| Lung | 1 | 2004 | 35 | 0.210 |
Why?
|
| Models, Biological | 1 | 2005 | 124 | 0.210 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 7 | 0.190 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 8 | 0.190 |
Why?
|
| Vimentin | 1 | 2022 | 5 | 0.190 |
Why?
|
| tau Proteins | 1 | 2022 | 6 | 0.190 |
Why?
|
| Mice, Transgenic | 1 | 2022 | 47 | 0.180 |
Why?
|
| Administration, Inhalation | 3 | 2007 | 5 | 0.180 |
Why?
|
| Biomarkers | 1 | 2022 | 81 | 0.180 |
Why?
|
| Structure-Activity Relationship | 2 | 2021 | 44 | 0.180 |
Why?
|
| alpha-Synuclein | 1 | 2021 | 3 | 0.180 |
Why?
|
| Indans | 1 | 2021 | 7 | 0.180 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 13 | 0.170 |
Why?
|
| Rats | 3 | 2007 | 241 | 0.160 |
Why?
|
| Molecular Conformation | 1 | 2018 | 27 | 0.140 |
Why?
|
| Humans | 6 | 2023 | 4936 | 0.130 |
Why?
|
| Models, Molecular | 1 | 2018 | 82 | 0.130 |
Why?
|
| Protein Binding | 1 | 2018 | 115 | 0.130 |
Why?
|
| Mice, Knockout | 1 | 2018 | 140 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2007 | 125 | 0.120 |
Why?
|
| Neuroimaging | 1 | 2016 | 18 | 0.120 |
Why?
|
| Brain | 1 | 2016 | 195 | 0.100 |
Why?
|
| Male | 2 | 2007 | 2491 | 0.070 |
Why?
|
| Capsules | 1 | 2007 | 1 | 0.060 |
Why?
|
| Aerosols | 1 | 2007 | 3 | 0.060 |
Why?
|
| Delayed-Action Preparations | 1 | 2006 | 4 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2006 | 29 | 0.060 |
Why?
|
| Folate Receptors, GPI-Anchored | 1 | 2005 | 1 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2005 | 6 | 0.060 |
Why?
|
| Urethane | 1 | 2004 | 1 | 0.060 |
Why?
|
| Polyethylene Glycols | 1 | 2004 | 27 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 160 | 0.050 |
Why?
|
| Indocyanine Green | 1 | 2023 | 3 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2023 | 17 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2023 | 32 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2021 | 3 | 0.040 |
Why?
|
| Protein Folding | 1 | 2021 | 14 | 0.040 |
Why?
|
| Drug Design | 1 | 2021 | 16 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 52 | 0.040 |
Why?
|
| Policy | 1 | 2021 | 3 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 84 | 0.040 |
Why?
|
| Hospitalization | 1 | 2021 | 38 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 73 | 0.040 |
Why?
|
| United States | 1 | 2021 | 495 | 0.040 |
Why?
|